Ferrer Invests More Than 60% of Its Net Profits in Social and Environmental Causes BARCELONA, Spain, July 28, 2022 (GLOBE NEWSWIRE) -- In 2021 the pharmaceutical company Ferrer invested 61.4% of its net profits in social and environmental causes, as part of its purpose to make a...

Ferrer Brings ALSton the Dragon to Life to Raise Awareness of ALS BARCELONA, Spain, June 21, 2022 (GLOBE NEWSWIRE) -- On Global Amyotrophic Lateral Sclerosis / Motor Neuron Disease (ALS/MND) Awareness Day on June 21, the Phantasticals campaign, run by Ferrer, the...

The First PHantasticals Come to Life to Raise Awareness of Pulmonary Hypertension BARCELONA, Spain, May 05, 2022 (GLOBE NEWSWIRE) -- Coinciding with World Pulmonary Hypertension (PH) Day, which is celebrated every May 5, Ferrer and the European Pulmonary Hypertension Association...

Ferrer Announces Distribution Agreement With United Therapeutics for Treprostinil Inhalation Solution for Pulmonary Hypertension Associated With Interstitial Lung Disease BARCELONA, Spain, Feb. 28, 2022 (GLOBE NEWSWIRE) -- In the run up to Rare Disease Day, which is held on 28 February, International pharmaceutical company Ferrer has strengthened its focus on...

Pharma Company Ferrer Certified B Corp for Its Positive Impact in Society BARCELONA, Spain, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Ferrer, the international pharmaceutical laboratory based in Barcelona, has become a B Corp company thanks to its positive impact in society and...